Pesquisar
Scinai Immunotherapeutics Ltd
SCNIAdicionar à lista de desejos
0.270USD
-0.001-0.29%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
956.00KValor de mercado
PerdaP/L TTM
Mais detalhes de Scinai Immunotherapeutics Ltd Empresa
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Informações de Scinai Immunotherapeutics Ltd
Código da empresaSCNI
Nome da EmpresaScinai Immunotherapeutics Ltd
Data de listagemJun 07, 2007
CEOReichman (Amir)
Número de funcionários31
Tipo de títulosDepository Receipt
Fim do ano fiscalJun 07
EndereçoJerusalem Biopark, 2Nd Floor
CidadeJERUSALEM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal00000
Telefone97289302529
Sitehttps://www.scinai.com/
Código da empresaSCNI
Data de listagemJun 07, 2007
CEOReichman (Amir)
Executivos da empresa Scinai Immunotherapeutics Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
400.02M
+100.00%
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
Dr. Yael Margolin
Dr. Yael Margolin
External Director
External Director
50.00
--
Mr. Adi Raviv
Mr. Adi Raviv
External Director
External Director
50.00
--
Mr. Samuel J. Moed
Mr. Samuel J. Moed
Director
Director
--
--
Dr. Morris C. Laster, M.D.
Dr. Morris C. Laster, M.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
400.02M
+100.00%
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
Perguntas frequentes
Quem são os cinco principais acionistas de Scinai Immunotherapeutics Ltd?
Os cinco principais acionistas de Scinai Immunotherapeutics Ltd são: Mr. Amir Reichman
Quantas instituições possuem ações da Scinai Immunotherapeutics Ltd (SCNI)?
Em 2026Q1, 23 instituições possuíam ações da Scinai Immunotherapeutics Ltd, com valor de mercado aproximado de 179.71K, representando 5.08% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 33890.00.